SMT201600041B - Agenti terapeutici 713 - Google Patents
Agenti terapeutici 713Info
- Publication number
- SMT201600041B SMT201600041B SM201600041T SM201600041T SMT201600041B SM T201600041 B SMT201600041 B SM T201600041B SM 201600041 T SM201600041 T SM 201600041T SM 201600041 T SM201600041 T SM 201600041T SM T201600041 B SMT201600041 B SM T201600041B
- Authority
- SM
- San Marino
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17463009P | 2009-05-01 | 2009-05-01 | |
| PCT/GB2010/050698 WO2010125390A1 (en) | 2009-05-01 | 2010-04-29 | Therapeutic agents 713 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT201600041B true SMT201600041B (it) | 2016-02-25 |
Family
ID=42290768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM201600041T SMT201600041B (it) | 2009-05-01 | 2016-02-11 | Agenti terapeutici 713 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8110566B2 (it) |
| EP (1) | EP2424870B1 (it) |
| JP (1) | JP5763052B2 (it) |
| KR (1) | KR20120023044A (it) |
| CN (2) | CN102459279B (it) |
| AR (1) | AR076516A1 (it) |
| AU (1) | AU2010243341B2 (it) |
| BR (1) | BRPI1014387A2 (it) |
| CA (1) | CA2759230A1 (it) |
| DK (1) | DK2424870T3 (it) |
| ES (1) | ES2562831T3 (it) |
| HR (1) | HRP20160128T1 (it) |
| HU (1) | HUE026856T2 (it) |
| MX (1) | MX2011011618A (it) |
| PL (1) | PL2424870T3 (it) |
| PT (1) | PT2424870E (it) |
| RU (1) | RU2526055C2 (it) |
| SA (1) | SA110310332B1 (it) |
| SI (1) | SI2424870T1 (it) |
| SM (1) | SMT201600041B (it) |
| TW (1) | TW201100433A (it) |
| UY (1) | UY32593A (it) |
| WO (1) | WO2010125390A1 (it) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100029685A1 (en) * | 2006-10-25 | 2010-02-04 | Neurosearch A/S | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| SG186275A1 (en) * | 2010-07-06 | 2013-01-30 | Astrazeneca Ab | Therapeutic agents 976 |
| UY34194A (es) | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? |
| HU230880B1 (hu) | 2015-04-15 | 2018-11-29 | Richter Gedeon Nyrt | Indol származékok |
| US12187722B2 (en) | 2019-03-15 | 2025-01-07 | The General Hospital Corporation | Small molecule inhibitors of TEAD transcription factors |
| AU2021206286A1 (en) * | 2020-01-10 | 2024-08-08 | Consynance Therapeutics, Inc. | Therapeutic combinations of drugs and methods of using them |
| HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL371435A1 (en) * | 2002-02-01 | 2005-06-13 | Novo Nordisk A/S | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| SE0202134D0 (sv) | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| DE60329513D1 (de) | 2002-07-30 | 2009-11-12 | Banyu Pharma Co Ltd | Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff |
| WO2004072018A1 (ja) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | アミン誘導体 |
| US20060293298A1 (en) * | 2003-04-10 | 2006-12-28 | Bamford Mark J | Compounds |
| GB0400193D0 (en) | 2004-01-07 | 2004-02-11 | Astrazeneca Ab | Therapeutic agents |
| JP2007517868A (ja) | 2004-01-07 | 2007-07-05 | アストラゼネカ アクチボラグ | 治療薬ｉ |
| US7241787B2 (en) | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| TW200538098A (en) | 2004-03-22 | 2005-12-01 | Astrazeneca Ab | Therapeutic agents |
| JP4982367B2 (ja) * | 2004-07-26 | 2012-07-25 | イーライ リリー アンド カンパニー | ヒスタミンｈ３受容体薬剤としてのオキサゾール誘導体、製造及び治療的使用 |
| US7846950B2 (en) | 2004-10-18 | 2010-12-07 | Eli Lilly And Company | Histamine H3 receptor inhibitors, preparation and therapeutic uses |
| CN101072775A (zh) | 2004-12-17 | 2007-11-14 | 伊莱利利公司 | 新的mch受体拮抗剂 |
| WO2006068594A1 (en) | 2004-12-21 | 2006-06-29 | Astrazeneca Ab | HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| JP2006176443A (ja) | 2004-12-22 | 2006-07-06 | Shionogi & Co Ltd | メラニン凝集ホルモン受容体アンタゴニスト |
| MX2007014464A (es) | 2005-05-31 | 2008-02-07 | Astrazeneca Ab | Antagonistas novedosos de mchr1 y sus usos para tratamiento de padecimientos y trastornos mediados por mchr1. |
| US20080221107A1 (en) | 2005-07-15 | 2008-09-11 | Astrazeneca Ab | Therapeutic Agents |
| UY30079A1 (es) | 2006-01-06 | 2007-08-31 | Astrazeneca Ab | Compuestos |
| US7666888B2 (en) | 2006-07-20 | 2010-02-23 | Amgen Inc. | Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 |
| JP2010501553A (ja) | 2006-08-18 | 2010-01-21 | アストラゼネカ アクチボラグ | Ｍｃｈｒ１アンタゴニストとしてのチエノピリミジン−４−オン誘導体およびチエノピリダジン−７−オン誘導体 |
| EP2102208B1 (en) | 2006-12-05 | 2014-04-23 | Janssen Pharmaceutica NV | Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| KR20090082484A (ko) | 2006-12-14 | 2009-07-30 | 일라이 릴리 앤드 캄파니 | 5-[4-(아제티딘-3-일옥시)-페닐]-2-페닐-5ｈ-티아졸로[5,4-ｃ]피리딘-4-온 유도체 및 ｍｃｈ 수용체 길항제로서의 이들의 용도 |
| WO2008131103A2 (en) | 2007-04-17 | 2008-10-30 | Vertex Pharmaceuticals Incorporated | Drug discovery methods for aurora kinase inhibitors |
| ATE519738T1 (de) | 2007-08-22 | 2011-08-15 | Hoffmann La Roche | Pyrrolidinarylether als nk3-rezeptorantagonisten |
| PL2212283T3 (pl) * | 2007-10-17 | 2012-01-31 | Sanofi Sa | Podstawione karboksyamidy N-fenylobipirolidyny i ich zastosowanie terapeutyczne |
| US20110071129A1 (en) * | 2008-06-19 | 2011-03-24 | Makoto Ando | Spirodiamine-diaryl ketoxime derivative |
-
2010
- 2010-04-28 SA SA110310332A patent/SA110310332B1/ar unknown
- 2010-04-29 KR KR1020117028655A patent/KR20120023044A/ko not_active Ceased
- 2010-04-29 TW TW099113722A patent/TW201100433A/zh unknown
- 2010-04-29 HR HRP20160128TT patent/HRP20160128T1/hr unknown
- 2010-04-29 RU RU2011147751/04A patent/RU2526055C2/ru not_active IP Right Cessation
- 2010-04-29 CA CA2759230A patent/CA2759230A1/en not_active Abandoned
- 2010-04-29 CN CN201080031068.6A patent/CN102459279B/zh not_active Expired - Fee Related
- 2010-04-29 HU HUE10718670A patent/HUE026856T2/en unknown
- 2010-04-29 MX MX2011011618A patent/MX2011011618A/es active IP Right Grant
- 2010-04-29 WO PCT/GB2010/050698 patent/WO2010125390A1/en not_active Ceased
- 2010-04-29 DK DK10718670.2T patent/DK2424870T3/en active
- 2010-04-29 PL PL10718670T patent/PL2424870T3/pl unknown
- 2010-04-29 PT PT107186702T patent/PT2424870E/pt unknown
- 2010-04-29 BR BRPI1014387A patent/BRPI1014387A2/pt not_active IP Right Cessation
- 2010-04-29 ES ES10718670.2T patent/ES2562831T3/es active Active
- 2010-04-29 EP EP10718670.2A patent/EP2424870B1/en not_active Not-in-force
- 2010-04-29 AU AU2010243341A patent/AU2010243341B2/en not_active Ceased
- 2010-04-29 JP JP2012507821A patent/JP5763052B2/ja not_active Expired - Fee Related
- 2010-04-29 SI SI201031124T patent/SI2424870T1/sl unknown
- 2010-04-29 CN CN201410183568.1A patent/CN103936751A/zh active Pending
- 2010-04-30 AR ARP100101476A patent/AR076516A1/es not_active Application Discontinuation
- 2010-04-30 UY UY0001032593A patent/UY32593A/es not_active Application Discontinuation
- 2010-04-30 US US12/771,594 patent/US8110566B2/en not_active Expired - Fee Related
-
2016
- 2016-02-11 SM SM201600041T patent/SMT201600041B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SA110310332B1 (ar) | 2013-12-10 |
| AR076516A1 (es) | 2011-06-15 |
| AU2010243341B2 (en) | 2014-02-13 |
| TW201100433A (en) | 2011-01-01 |
| DK2424870T3 (en) | 2016-02-15 |
| CN103936751A (zh) | 2014-07-23 |
| JP5763052B2 (ja) | 2015-08-12 |
| PT2424870E (pt) | 2016-03-17 |
| ES2562831T3 (es) | 2016-03-08 |
| CA2759230A1 (en) | 2010-11-04 |
| US8110566B2 (en) | 2012-02-07 |
| KR20120023044A (ko) | 2012-03-12 |
| PL2424870T3 (pl) | 2016-05-31 |
| US20100280000A1 (en) | 2010-11-04 |
| SI2424870T1 (sl) | 2016-03-31 |
| AU2010243341A1 (en) | 2011-11-03 |
| CN102459279A (zh) | 2012-05-16 |
| JP2012525365A (ja) | 2012-10-22 |
| WO2010125390A1 (en) | 2010-11-04 |
| EP2424870A1 (en) | 2012-03-07 |
| HUE026856T2 (en) | 2016-07-28 |
| UY32593A (es) | 2010-11-30 |
| MX2011011618A (es) | 2011-11-18 |
| EP2424870B1 (en) | 2015-12-16 |
| CN102459279B (zh) | 2014-06-25 |
| HRP20160128T1 (hr) | 2016-02-26 |
| BRPI1014387A2 (pt) | 2017-06-06 |
| RU2526055C2 (ru) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0916931A2 (pt) | agentes terapêuticos | |
| DK2144905T3 (da) | Terapeutiske midler | |
| BR112012004546A2 (pt) | "terapêutica por proteínas ligantes dll4-ligantes" | |
| SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
| BR112012012872A2 (pt) | "pirrolindinas de espiroindolinona" | |
| BRPI1010909A2 (pt) | "inseticida arilpirrolinas" | |
| PT2448582T (pt) | Compostos e composições terapêuticas | |
| BRPI1012004A2 (pt) | "forma farmacêutica" | |
| GB0811304D0 (en) | Therapeutic agents | |
| EP2471786A4 (en) | aminopyrazole derivative | |
| BRPI1013015A2 (pt) | "osteosíntese com nanoprata" | |
| DK2185142T3 (da) | Antiseptiske midler | |
| GB0819593D0 (en) | Therapeutic agents | |
| GB0821693D0 (en) | Therapeutic agents | |
| GB0801081D0 (en) | Therapeutic agents | |
| GB0801080D0 (en) | Therapeutic agents | |
| SMT201600041B (it) | Agenti terapeutici 713 | |
| GB0812309D0 (en) | Therapeutic agents | |
| BRPI0820410A2 (pt) | Lactans substituídos terapêuticos | |
| GB0805818D0 (en) | Therapeutic agents | |
| BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
| EP2454248A4 (en) | ANTI FLU RESOURCES | |
| BRPI1006474A2 (pt) | "gatilho" | |
| BRPI0909764A2 (pt) | compostos terapêuticos | |
| MA30860B1 (fr) | Myrtillier denomme "c97-390" |